SCOPUS
Medicine in Drug Discovery
Elsevier, Netherlands
Medicine in Drug Discovery is an academic journal published by Elsevier (Netherlands). Identifiers: eISSN 2590-0986. Indexed in SCOPUS. Metrics: CiteScore 10.8, SJR 1.034, SNIP 0.89. tlooto lists 268 papers from this journal.
CiteScore
10.80
Scopus citation metric
SJR
1.034
SCImago rank
SNIP
0.89
Source normalized impact
Percentage rank
-
JIF percentile rank
Journal profile
- ISSN
- -
- eISSN
- 2590-0986
- Abbreviation
- -
- Publisher
- Elsevier
- Country
- Netherlands
Web of Science categories
No Web of Science category data available.
Scopus ASJC categories
2736 Pharmacology (medical)3002 Drug Discovery3004 Pharmacology
Papers in this journal
Recent papers
- Enhancing the therapeutic potential of plumbagin in breast cancer via advanced nanomedicine approaches
2026
- Inhibition of α-glucosidase by melatonin derivatives: insights from kinetics, docking, and molecular dynamics simulations
2026
- Energy-based method for designing aptamers to target phosphatidylcholine
2026 · 1 citations
- Intravenous and oral NOAEL doses of the new PrC-210 aminothiol in swine and dose equivalency in humans to enable clinical trials
2026 · 1 citations
- Antiphotoaging and anti-inflammatory effects of Malaysian brown seaweed Sargassum aquifolium: Cellular insights from HaCaT and RAW 264.7 models and metabolite profiling via LC-MS
2026
Most cited papers
- Vascular Endothelial Growth Factor Receptor (VEGFR-2)/KDR Inhibitors: Medicinal Chemistry Perspective
2019 · 284 citations
- Can early and high intravenous dose of vitamin C prevent and treat coronavirus disease 2019 (COVID-19)?
2020 · 194 citations
- The new SARS-CoV-2 strain shows a stronger binding affinity to ACE2 due to N501Y mutant
2021 · 156 citations
- Development and Clinical Application of Phosphorus-Containing Drugs
2020 · 151 citations
- Mesenchymal stem cells and management of COVID-19 pneumonia
2020 · 131 citations